Understanding OCD: New Research Focus on Treatment
Approximately 2% of the global population, equating to around 163 million individuals, battles obsessive-compulsive disorder (OCD), which is characterized by recurring unwanted thoughts and repetitive behaviors aimed at reducing distress. Carolyn Rodriguez, a Stanford physician involved in OCD research, highlights that while there are recognizable symptoms portrayed in media, OCD can manifest in various forms that are frequently overlooked by both patients and healthcare providers. She emphasizes the need for more awareness regarding the disorder’s complexity as it remains poorly understood.
Many patients diagnosed with OCD often find little relief from traditional treatments like serotonin reuptake inhibitors or exposure and response prevention. To address this gap, Rodriguez is working to broaden the scope of research and is investigating innovative treatment methods, such as ketamine. For those interested in participating in her ketamine study, contact can be made through the provided email or phone number. To access more resources, individuals can check out her lab’s webpage as well as the International OCD Foundation. Read more.
